Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は Princeton, DE, アメリカ. 現CEOは Christopher S. Boerner.
BMYMP を有する IPO日 2003-12-08, 34,100 名の正社員, に上場 Other OTC.
Bristol-Myers Squibb is a global pharmaceutical company that discovers, develops, and markets innovative drugs across multiple therapeutic areas, including cardiovascular disease, cancer, and immune disorders. The company has established itself as a leader in immuno-oncology, a rapidly growing field combining immunotherapy with cancer treatment. With approximately 70% of its revenue generated from the United States market, Bristol-Myers Squibb demonstrates a significant concentration in the U.S. compared to many of its industry peers, reflecting its strong presence in the world's largest pharmaceutical market.
